BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/27/2024 11:58:45 AM | Browse: 220 | Download: 467
 |
Received |
|
2023-11-30 14:42 |
|
Peer-Review Started |
|
2023-11-30 14:42 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-12-08 17:53 |
|
Revised |
|
2023-12-22 02:06 |
|
Second Decision |
|
2024-01-16 02:44 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-01-16 07:07 |
|
Articles in Press |
|
2024-01-16 07:07 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-02-19 02:57 |
|
Publish the Manuscript Online |
|
2024-02-27 11:58 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Autoimmune hepatitis and primary sclerosing cholangitis after direct-acting antiviral treatment for hepatitis C virus: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yoshiki Morihisa, Hobyung Chung, Shuichiro Towatari, Daisuke Yamashita and Tetsuro Inokuma |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hobyung Chung, MD, PhD, Doctor, Doctor, Department of Gastroenterology and Hepatology, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminami-machi, Chuo-ku, Kobe 650-0047, Hyogo, Japan. teihiroshi@gmail.com |
| Key Words |
Liver; Hepatitis C virus; Autoimmune hepatitis; Primary sclerosing cholangitis; Immune system; Case report |
| Core Tip |
Direct-acting antivirals (DAAs) for chronic hepatitis C virus (HCV) infection are widely used as a safe and effective treatment intervention. Chronic HCV infection alters the innate and adaptive immune responses, both functionally and phenotypically. Rapid viral clearance following DAAs treatment restores adaptive immune function. Herein, we report a rare case of autoimmune hepatitis and primary sclerosing cholangitis that developed after DAAs treatment for HCV. The potential risk of developing autoimmune liver diseases after DAAs treatment owing to the restoration of host immunity following rapid viral clearance should be considered. |
| Publish Date |
2024-02-27 11:58 |
| Citation |
Morihisa Y, Chung H, Towatari S, Yamashita D, Inokuma T. Autoimmune hepatitis and primary sclerosing cholangitis after direct-acting antiviral treatment for hepatitis C virus: A case report. World J Hepatol 2024; 16(2): 286-293 |
| URL |
https://www.wjgnet.com/1948-5182/full/v16/i2/286.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v16.i2.286 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
